Mounjaro and Dental Work: What Your Dentist Needs to Know

Step 1, Tell your dentist you're taking tirzepatide before the appointment begins

This is the single most useful thing you can do. Dentists routinely ask about prescribed medicines at the start of a course of treatment, but the update question at each visit is easy to overlook. Mounjaro isn't a medicine most dentists encounter daily, so bring the name of the active ingredient (tirzepatide) as well as the strength you're on, in case the brand name draws a blank.

Why does it matter? Tirzepatide acts on GIP and GLP-1 receptors in the gut, reducing appetite partly by slowing how quickly your stomach clears food and fluid. For routine fillings or hygiene appointments with local anaesthetic only, this has no direct bearing on your safety. For anything involving sedation (intravenous or inhalation) or a general anaesthetic, it becomes clinically significant. The stomach-emptying question matters because the risk of aspirating gastric contents during sedation is higher when the stomach hasn't cleared as expected. You can read more about how the medicine's gut mechanism works on our Mounjaro mechanism page.

The NHS England guidance on weight-management injections specifically advises patients to inform all members of their healthcare team, including anaesthetists, before any procedure. Your dentist is part of that team.

Step 2, Flag it again if sedation or general anaesthesia is on the table

For straightforward dental work under local anaesthetic, Mounjaro doesn't require you to stop treatment or change your dose schedule. The conversation with your dentist is informational rather than a red flag. Sedation is a different matter. If your dental plan involves conscious sedation or if you're being referred for a procedure under general anaesthetic, your dentist, anaesthetist and prescriber need to communicate directly about fasting guidance and timing.

Standard pre-operative fasting rules (typically nothing to eat for six hours and clear fluids up to two hours before) were designed for people with normal gastric motility. When gastric emptying is delayed, those standard windows may not be sufficient. Your anaesthetist may extend the fasting period or request that you discuss holding a dose with your prescriber before the procedure. That decision belongs with them, not with general advice online. Our page on Mounjaro and dental anaesthesia covers the sedation-specific considerations in more depth.

One misconception worth setting aside gently: some people assume that because tirzepatide is a weekly injection rather than a daily tablet, missing or delaying one dose for surgery is straightforward, and if you'd like to understand more about how tirzepatide is administered and why the route matters, that page explains the pharmacology behind the weekly schedule. The timing of any change should be agreed with your prescriber rather than decided independently.

Step 3, Keep an eye on oral health side effects throughout treatment

A few of tirzepatide's known side effects have a slow, cumulative effect on your mouth rather than an acute one. Nausea and vomiting, particularly in the first weeks of treatment or after a dose increase, expose tooth enamel to stomach acid. If you're experiencing persistent nausea, rinsing with water after any vomiting episode (rather than immediately brushing) helps limit enamel erosion. Brushing straight after acid exposure can actually increase damage.

Dry mouth is reported by some patients on GLP-1 and dual-agonist medicines, though it's less commonly listed in the formal side-effect data than the gastrointestinal effects. Saliva plays a protective role, it buffers acids and limits bacterial growth. If your mouth feels persistently drier than usual, mention it to your dentist and your prescriber. Staying well hydrated matters anyway on tirzepatide, and it's one of the easier things to act on. The NHS tirzepatide medicine guide lists the full common side-effect profile.

Reduced appetite during treatment also means some patients eat less frequently, which can inadvertently reduce the number of times teeth are exposed to food acids. That's not necessarily a concern, but it is a change worth mentioning at your hygiene check-up so your dentist has the full picture of what your eating pattern looks like now versus before treatment started. For a broader look at what might affect how well treatment is working alongside lifestyle changes, the page on why Mounjaro may not work as expected is worth a read.

Step 4 (Keep your prescriber and GP informed about any significant dental procedures

For planned procedures) extractions, implant work, oral surgery, loop your prescriber in ahead of time. They may want to review your dose timing or coordinate with the surgical team. If you hold treatment ahead of a procedure, your prescriber is the right person to guide you back to your usual schedule afterwards, based on how you're recovering and eating.

GP notification is part of how responsible prescribing works. At nume, our clinical team follows GPhC guidance on informing your GP when treatment starts, so your Summary Care Record reflects your current medicines. That matters when any other healthcare professional, including a dental surgeon, needs a complete picture quickly. You can find out more about how our service is structured and the clinical oversight behind it. For a broader overview of the treatment itself, the Mounjaro information page covers the licensed indication, eligibility and what the clinical evidence says.

If you're in the middle of treatment and you have questions specific to your situation, our aftercare team is available seven days a week. And if you haven't yet started treatment, our consultation page is the place to begin, a GPhC-registered prescriber, not an algorithm, reads every application the same day it arrives. It's also worth knowing that Mounjaro can have effects on mental health and emotional wellbeing, something our clinical team takes into account as part of ongoing care. The NHS England guidance on weight-management injections is also a reliable reference for the broader clinical context around GLP-1 and dual-agonist medicines.